146 related articles for article (PubMed ID: 24856264)
21. Drugs of abuse-induced hyperthermia, blood-brain barrier dysfunction and neurotoxicity: neuroprotective effects of a new antioxidant compound H-290/51.
Sharma HS; Sjöquist PO; Ali SF
Curr Pharm Des; 2007; 13(18):1903-23. PubMed ID: 17584116
[TBL] [Abstract][Full Text] [Related]
22. Cognitive deficits among methamphetamine users with attention deficit hyperactivity disorder symptomatology.
Sim T; Simon SL; Domier CP; Richardson K; Rawson RA; Ling W
J Addict Dis; 2002; 21(1):75-89. PubMed ID: 11831502
[TBL] [Abstract][Full Text] [Related]
23. 3,4-Methylenedioxymethamphetamine (MDMA) abuse may cause oxidative stress and potential free radical damage.
Zhou JF; Chen P; Zhou YH; Zhang L; Chen HH
Free Radic Res; 2003 May; 37(5):491-7. PubMed ID: 12797468
[TBL] [Abstract][Full Text] [Related]
24. Nitric oxide and lipid peroxidation are increased and associated with decreased antioxidant enzyme activities in patients with age-related macular degeneration.
Evereklioglu C; Er H; Doganay S; Cekmen M; Turkoz Y; Otlu B; Ozerol E
Doc Ophthalmol; 2003 Mar; 106(2):129-36. PubMed ID: 12678277
[TBL] [Abstract][Full Text] [Related]
25. Serum total antioxidant status and lipid peroxidation marker malondialdehyde levels in overt and subclinical hypothyroidism.
Torun AN; Kulaksizoglu S; Kulaksizoglu M; Pamuk BO; Isbilen E; Tutuncu NB
Clin Endocrinol (Oxf); 2009 Mar; 70(3):469-74. PubMed ID: 18727709
[TBL] [Abstract][Full Text] [Related]
26. Effect of methamphetamine on the fasting blood glucose in methamphetamine abusers.
Zhang Y; Shu G; Bai Y; Chao J; Chen X; Yao H
Metab Brain Dis; 2018 Oct; 33(5):1585-1597. PubMed ID: 29946958
[TBL] [Abstract][Full Text] [Related]
27. Possible action mechanism for curcumin in pre-cancerous lesions based on serum and salivary markers of oxidative stress.
Rai B; Kaur J; Jacobs R; Singh J
J Oral Sci; 2010 Jun; 52(2):251-6. PubMed ID: 20587949
[TBL] [Abstract][Full Text] [Related]
28. N-acetylcysteine amide protects against methamphetamine-induced tissue damage in CD-1 mice.
Zhang X; Tobwala S; Ercal N
Hum Exp Toxicol; 2012 Sep; 31(9):931-44. PubMed ID: 22354084
[TBL] [Abstract][Full Text] [Related]
29. Methamphetamine causes microglial activation in the brains of human abusers.
Sekine Y; Ouchi Y; Sugihara G; Takei N; Yoshikawa E; Nakamura K; Iwata Y; Tsuchiya KJ; Suda S; Suzuki K; Kawai M; Takebayashi K; Yamamoto S; Matsuzaki H; Ueki T; Mori N; Gold MS; Cadet JL
J Neurosci; 2008 May; 28(22):5756-61. PubMed ID: 18509037
[TBL] [Abstract][Full Text] [Related]
30. Increased blood 8-hydroxy-2-deoxyguanosine levels in methamphetamine users during early abstinence.
Huang MC; Lai YC; Lin SK; Chen CH
Am J Drug Alcohol Abuse; 2018; 44(3):395-402. PubMed ID: 28726514
[TBL] [Abstract][Full Text] [Related]
31. Polymorphisms in CYP2D6 may predict methamphetamine related heart failure.
Sutter ME; Gaedigk A; Albertson TE; Southard J; Owen KP; Mills LD; Diercks DB
Clin Toxicol (Phila); 2013 Aug; 51(7):540-4. PubMed ID: 23855716
[TBL] [Abstract][Full Text] [Related]
32. Cognitive Deficits in Methamphetamine Users: How Strong is The Evidence?
Proebstl L; Kamp F; Koller G; Soyka M
Pharmacopsychiatry; 2018 Nov; 51(6):243-250. PubMed ID: 29334687
[TBL] [Abstract][Full Text] [Related]
33. Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence.
Longo M; Wickes W; Smout M; Harrison S; Cahill S; White JM
Addiction; 2010 Jan; 105(1):146-54. PubMed ID: 19839966
[TBL] [Abstract][Full Text] [Related]
34. Oxidative stress in hemodialysis patients receiving intravenous iron therapy and the role of N-acetylcysteine in preventing oxidative stress.
Swarnalatha G; Ram R; Neela P; Naidu MU; Dakshina Murty KV
Saudi J Kidney Dis Transpl; 2010 Sep; 21(5):852-8. PubMed ID: 20814119
[TBL] [Abstract][Full Text] [Related]
35. 3,4-methylenedioxymethamphetamine (MDMA) abuse markedly inhibits acetylcholinesterase activity and induces severe oxidative damage and liperoxidative damage.
Zhou JF; Zhou YH; Zhang L; Chen HH; Cai D
Biomed Environ Sci; 2003 Mar; 16(1):53-61. PubMed ID: 12747008
[TBL] [Abstract][Full Text] [Related]
36. Pulmonary arterial hypertension seen in methamphetamine abusers.
Thompson CA
Am J Health Syst Pharm; 2008 Jun; 65(12):1109-10. PubMed ID: 18541676
[No Abstract] [Full Text] [Related]
37. Drugs of abuse and blood-brain barrier endothelial dysfunction: A focus on the role of oxidative stress.
Sajja RK; Rahman S; Cucullo L
J Cereb Blood Flow Metab; 2016 Mar; 36(3):539-54. PubMed ID: 26661236
[TBL] [Abstract][Full Text] [Related]
38. Electrocardiographic abnormalities in methamphetamine abusers.
Haning W; Goebert D
Addiction; 2007 Apr; 102 Suppl 1():70-5. PubMed ID: 17493055
[TBL] [Abstract][Full Text] [Related]
39. Orexin-A level elevation in recently abstinent male methamphetamine abusers.
Chen WY; Kao CF; Chen PY; Lin SK; Huang MC
Psychiatry Res; 2016 May; 239():9-11. PubMed ID: 27137956
[TBL] [Abstract][Full Text] [Related]
40. Duration of detection of methamphetamine in hair after abstinence.
Suwannachom N; Thananchai T; Junkuy A; O'Brien TE; Sribanditmongkol P
Forensic Sci Int; 2015 Sep; 254():80-6. PubMed ID: 26197350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
